Recruiting
HIV infection+1
RecruitingStudy on Reducing HIV-HBV Treatment with Darunavir, Ritonavir, and Lamivudine for Patients with Controlled Co-Infection
Registered drugNo placebo
Study on Reducing HIV-HBV Treatment with Darunavir, Ritonavir, and Lamivudine for Patients with Controlled Co-Infection
Registered drugNo placebo
- Disease:HIV infectionHepatitis B virus test
- Substances:DarunavirDolutegravir Sodium+2
Countries:
France
France- Participants:18–64 years
- Substances:Darunavir
- Sponsor:Institut National De La Sante Et De La Recherche Medicale


